We expect to see more pack trade-offs in potato chips, soft drinks and cold cereal but we also see outsized pack trade-offs in coffee and granola, which implies two emerging trends in the GLP-1 population: a general decrease in snacking, even for snacks usually considered healthy, and overall collateral damage that is spreading to categories that should not be greatly affected by GLP-1 status. In addition to their impact on the retail food and beverage market, oral GLP-1 medications are expected to account for 20% of total GLP-1 drug sales by 2031, with a pill market that is estimated to grow from $3.2 billion in 2025 to $34.3 billion in 2031, according to GlobalData.
"Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss"
Gemss Asadi et al
doi: 10.1016/j.cmet.2008.03.006 108 LiuJCondeKZhangPLilascharoenV
The preparation of these capsules involves the use of some well-known potent herbs, including Manjistha (Rubia cordifolia), Chirata (Swertia chiretta), Pit papda (Fumaria officianalis), and Grit kumari (Aloe barbadensis)
These medications are intended for people with obesity or those who are overweight with related health issues